GenWealth Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $516K | Sell |
1,425
-3
| -0.2% | -$1.03K | 0.08% | 54 |
|
|
2026
Q1 | $502K | Sell |
1,428
-17
| -1% | -$6.06K | 0.09% | 53 |
|
|
2025
Q4 | $477K | Buy |
1,445
+71
| +5% | +$22.5K | 0.08% | 57 |
|
|
2025
Q3 | $388K | Hold |
1,374
| – | – | 0.07% | 56 |
|
|
2025
Q2 | $384K | Hold |
1,374
| – | – | 0.08% | 54 |
|
|
2025
Q1 | $428K | Hold |
1,374
| – | – | 0.09% | 51 |
|
|
2024
Q4 | $358K | Hold |
1,374
| – | – | 0.08% | 52 |
|
|
2024
Q3 | $443K | Hold |
1,374
| – | – | 0.1% | 52 |
|
|
2024
Q2 | $429K | Hold |
1,374
| – | – | 0.11% | 49 |
|
|
2024
Q1 | $391K | Hold |
1,374
| – | – | 0.1% | 50 |
|
|
2023
Q4 | $396K | Hold |
1,374
| – | – | 0.11% | 55 |
|
|
2023
Q3 | $369K | Hold |
1,374
| – | – | 0.11% | 53 |
|
|
2023
Q2 | $305K | Hold |
1,374
| – | – | 0.09% | 60 |
|
|
2023
Q1 | $332K | Hold |
1,374
| – | – | 0.1% | 57 |
|
|
2022
Q4 | $361K | Hold |
1,374
| – | – | 0.12% | 56 |
|
|
2022
Q3 | $310K | Hold |
1,374
| – | – | 0.11% | 45 |
|
|
2022
Q2 | $334K | Hold |
1,374
| – | – | 0.11% | 43 |
|
|
2022
Q1 | $332K | Hold |
1,374
| – | – | 0.09% | 55 |
|
|
2021
Q4 | $309K | Hold |
1,374
| – | – | 0.08% | 55 |
|
|
2021
Q3 | $292K | Sell |
1,374
-89
| -6% | -$20.5K | 0.09% | 55 |
|
|
2021
Q2 | $356K | Hold |
1,463
| – | – | 0.11% | 51 |
|
|
2021
Q1 | $364K | Hold |
1,463
| – | – | 0.12% | 50 |
|
|
2020
Q4 | $336K | Hold |
1,463
| – | – | 0.11% | 55 |
|
|
2020
Q3 | $377K | Sell |
1,463
-13
| -0.9% | -$3.22K | 0.14% | 51 |
|
|
2020
Q2 | $377K | Sell |
1,476
-5
| -0.3% | -$1.14K | 0.15% | 52 |
|
|
2020
Q1 | $300K | Sell |
1,481
-1,429
| -49% | -$312K | 0.13% | 45 |
|
|
2019
Q4 | $701K | Hold |
2,910
| – | – | 0.27% | 39 |
|
|
2019
Q3 | $563K | Hold |
2,910
| – | – | 0.23% | 42 |
|
|
2019
Q2 | $543K | Buy |
2,910
+5
| +0.2% | +$895 | 0.23% | 42 |
|
|
2019
Q1 | $557K | Buy |
2,905
+50
| +2% | +$9.55K | 0.25% | 36 |
|
|
2018
Q4 | $555K | Hold |
2,855
| – | – | 0.28% | 31 |
|
|
2018
Q3 | $592K | Hold |
2,855
| – | – | 0.27% | 33 |
|
|
2018
Q2 | $530K | Hold |
2,855
| – | – | 0.26% | 33 |
|
|
2018
Q1 | $486K | Buy |
2,855
+103
| +4% | +$18.9K | 0.25% | 34 |
|
|
2017
Q4 | $529K | Buy |
+2,752
| New | +$487K | 0.27% | 34 |
|
Other funds holding AMGN
FFM
GenWealth Group's AMGN Position: Q2 2026 in Review
GenWealth Group reduced its Amgen (AMGN) stake by 0.21% in Q2 2026, selling an estimated $1.03K and leaving 1,425 shares worth $516K. The position accounts for 0.08% of the portfolio, ranked #54.
GenWealth Group first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $701K in Q4 2019. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- GenWealth Group held 1,425 shares of Amgen worth $516K as of Q2 2026.
- GenWealth Group sold 3 Amgen shares in Q2 2026, an estimated $1.03K.
- Amgen made up 0.08% of GenWealth Group's portfolio in Q2 2026, its #54 holding.
- GenWealth Group first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- GenWealth Group's Amgen position peaked at $701K in Q4 2019.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on GenWealth Group's 13F filing for Q2 2026, filed 10 Jul 2026.